On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Flavio Vincenti

ResearcherPublications, citations & collaboration network

Flavio Vincenti is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Flavio Vincenti have?

ScholarIQindexed works

Flavio Vincenti has 376 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Flavio Vincenti have?

ScholarIQcitation count

Flavio Vincenti has 24,450 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Flavio Vincenti?

ScholarIQh-index

Flavio Vincenti has an h-index of 77 in OpenAlex.

What is the i10-index of Flavio Vincenti?

ScholarIQi10-index

Flavio Vincenti has an i10-index of 213 in OpenAlex.

What is the ORCID of Flavio Vincenti?

ScholarIQorcid

The ORCID for Flavio Vincenti is on the source record.

What is the OpenAlex record for Flavio Vincenti?

ScholarIQopenalex

The OpenAlex for Flavio Vincenti is on the source record.

What are the most-cited papers on Flavio Vincenti?

ScholarIQmost cited works
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
Bertram L. Kasiske, Martin Zeier, Jeremy R. Chapman, Jonathan C. Craig, Henrik Ekberg, Catherine Garvey, Michael D. Green, Vivekanand Jha, Michelle A. Josephson, Bryce Kiberd, Henri Kreis, Ruth A. McDonald, John M. Newmann, Gregorio T. Obrador, Flavio Vincenti, Michael Cheung, Amy Earley, Gowri Raman, Samuel A. Abariga, Martin Wagner, Ethan M. Balk
Kidney International. 20091,737 Citations
Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus
Flavio Vincenti, S. Friman, Ernst‐Heinrich Scheuermann, Lionel Rostaing, Trond Jenssen, Josep M. Campistol, Kazuharu Uchida, Mark D. Pescovitz, Piero Marchetti, Murat Tuncer, Franco Citterio, Andrzej Więcek, Steven J. Chadban, M. El-Shahawy, Klemens Budde, Norihiko Goto
American Journal of Transplantation. 2007618 CitationsOPEN ACCESS
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
Howard Trachtman, Fernando C. Fervenza, Debbie S. Gipson, Peter Heering, David Jayne, Harm Peters, Stefano Rota, Giuseppe Remuzzi, Lars Christian Rump, Lorenz Sellin, Jeremy P.W. Heaton, James B. Streisand, Marjie Hard, Steven Ledbetter, Flavio Vincenti
Kidney International. 2011260 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account